Board members of the European Society of Gene and Cell Therapy

The ESGCT Board is composed of researchers and clinicians representing a broad range of European Countries. Board members are elected by nomination and vote at the Annual General Meeting which is usually held during the Annual Congress.

The President and Vice-President of the society are appointed for two years and the other members of the Board are appointed for three years. For full details of governance arrangements please see section 4 of the society constitution. If you would like to express an interest in becoming a Board member please don’t hesitate to contact for details of the nomination process.

Robin AliRobin Ali


Institute of Ophthalmology
University College London
Bath St
EC1V 9EL London

Hildegard Büning

Hildegard Büning

Vice President

Institute of Experimental Hematology
Hannover Medical School
Carl-Neuberg-Str. 1
30625 Hannover

Christof von Kalle Treasurer

Christof von Kalle


National Center for Tumor Diseases (NCT) Heidelberg
Im Neuenheimer Feld 460
69120 Heidelberg

Juan Bueren

General Secretary

División de Terapias Innovadoras en el Sistema Hematopoyético
Av. Complutense, 40
28040 Madrid

Alessandro Aiuti

"Università Vita Salute San Raffaele" School of Medicine
San Raffaele Telethon Institute for Gene Therapy via Olgettina 58,
20132 Milano

Alberto Auricchio

Telethon Institute Of Genetics And Medicine
Via Pietro Castellino, 111
80131 Naples

Nathalie Cartier-LacaveNathalie Cartier-Lacave

18 route du Panorama,
92265 Fontenay aux Roses

Vincenzo Cerullo

Drug Research Program Faculty of Pharmacy
University of Helsinki
Biocenter 2 Viikinkaari 5E, 
00790 Helsinki 

Zoltan Ivics

Zoltan Ivics

Division of Medical Biotechnology
Paul Ehrlich Institute
Paul Ehrlich Str. 51-59
63225 Langen

Adrian Thrasher

University College London
Gower Street



Joost van Haasteren

Student Board Member


Larisa Condurat

Student Board Member


Gaelle Jamar

Congress Manager